These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6426813)

  • 1. Serum selenium in patients with ovarian cancer during and after therapy.
    Sundström H; Yrjänheikki E; Kauppila A
    Carcinogenesis; 1984 Jun; 5(6):731-4. PubMed ID: 6426813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy.
    Sieja K; Talerczyk M
    Gynecol Oncol; 2004 May; 93(2):320-7. PubMed ID: 15099940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum selenium and thromboxane in patients with gynaecological cancer.
    Sundström H; Ylikorkala O; Kauppila A
    Carcinogenesis; 1986 Jul; 7(7):1051-2. PubMed ID: 3719901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination chemotherapy of ovarian cancer with cisplatinum, aclarubicin and tegafur].
    Wada Y; Suzuki M; Shinagawa S; Saito Y; Nishiya I; Maki M; Yajima A; Hiroi M; Sato A
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2589-94. PubMed ID: 2505683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of 2 different forms of chemotherapy on remission in patients with advanced ovarian cancer].
    Krommer K; Keller G; Csaba I; Garadnay B; Göcze P
    Zentralbl Gynakol; 1990; 112(17):1105-10. PubMed ID: 2264421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic results of malignant ovarian tumor].
    Fukazawa I; Masubuchi S; Okajima H; Fukuda K; Hayashi K; Yokosuka K; Miyata R; Masubuchi K
    Gan No Rinsho; 1984 Jun; 30(7):819-26. PubMed ID: 6431145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
    Mäenpää J; Kangas L; Grönroos M
    Obstet Gynecol; 1985 Nov; 66(5):708-13. PubMed ID: 3932908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of relationship between level of serum selenium and syndrome differentiation and typing of traditional Chinese medicine in lung cancer].
    Mi YY; Hu YJ; Zhou MZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Nov; 15(11):658-60. PubMed ID: 8732150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer. Gruppo Interegionale Cooperativo Oncologico Ginecologia.
    Lancet; 1987 Aug; 2(8555):353-9. PubMed ID: 2886821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selecting postoperative chemotherapy regimen and optimizing therapy cycle for stage II-IV ovarian epithelial carcinoma].
    Huang YW; Li YJ; Li MD
    Ai Zheng; 2005 Aug; 24(8):994-7. PubMed ID: 16086880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of advanced ovarian cancer. Göttingen-Hannover studies].
    Kühnle H; Hilfrich J
    Onkologie; 1985 Dec; 8(6):374-82. PubMed ID: 3912694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging.
    Shimada M; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Minagawa Y; Ishihara K; Takeuchi Y; Okada M; Terakawa N
    Int J Gynecol Cancer; 2005; 15(4):601-5. PubMed ID: 16014112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of ovarian cancer].
    Kato T; Nishimura H
    Gan No Rinsho; 1989 Jan; Spec No():392-8. PubMed ID: 2464708
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of 3-drug therapy in patients with advanced ovarian cancer].
    Kwaśniewska-Rokicińska C; Kaleta B; Kumor-Głodny T
    Ginekol Pol; 1989 Feb; 60(2):86-9. PubMed ID: 2680790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy in clinical stage III cancer of the ovary. Use of 1 and 2 agents].
    Torres Lobatón A; García Baños J; Nieto Riande P; Flores López G; Martínez Macías R
    Ginecol Obstet Mex; 1986 Jan; 54():3-7. PubMed ID: 3699490
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
    Morgan RJ; Braly P; Cecchi G; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Parker P; Stein A; Cho J; Smith E; Coluzzi P; Najera L; Johnson D; Womack E; Doroshow JH
    Gynecol Oncol; 1999 Dec; 75(3):419-26. PubMed ID: 10600300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A combination of cyclophosphamide, adriamycin and platinum (CAP) in the treatment of stage III and IV ovarian cancer].
    Chylak V; Krusić J; Kolarić K
    Jugosl Ginekol Perinatol; 1988; 28(1-2):41-3. PubMed ID: 3398564
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of second look surgery in the therapy of ovarian cancer].
    Sasaki H; Ochiai K; Terashima Y
    Gan No Rinsho; 1990 Aug; 36(10):1174-8. PubMed ID: 2214157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment serum hemoglobin level and a preliminary investigation of intratumoral microvessel density in advanced ovarian cancer.
    Ferrero A; Zola P; Mazzola S; Fuso L; Sarotto I; Ravarino N; Spanu PG; Jacomuzzi ME; Carus AP; Sismondi P
    Gynecol Oncol; 2004 Nov; 95(2):323-9. PubMed ID: 15491752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma.
    Wils J; Blijham G; Naus A; Belder C; Boschma F; Bron H; Ceelen T; Eekhout A; von Erp J; Geelen P
    J Clin Oncol; 1986 Jul; 4(7):1068-73. PubMed ID: 3723166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.